Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Benzocycloheptenes as PGI2 agonists in early development at Fujisawa

June 18, 1999

Two-step inactivation procedure eliminates blood-borne viruses in FANDHI

June 14, 1999

Stage I of phase III Neutralase study completed

June 14, 1999

Roberts' Agrylin receives orphan drug status in Japan

June 10, 1999

Elevated troponin T levels predict beneficial response to abciximab in unstable angina

June 8, 1999

Potent, orally active antiplatelet fibrinogen antagonists in early development at Ortho-McNeil

June 8, 1999

Chiron begins first clinical trial of in vivo gene therapy for hemophilia

June 4, 1999

PGI2 agonists under study at Fujisawa

June 2, 1999

Orally active anticoagulants described by Daiichi

June 2, 1999

New perspectives for rFVIIa and rFVIIai

June 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...